GLP-1 receptor agonists and basal insulin in type 2 diabetes

Lancet. 2014 Dec 20;384(9961):2180-1. doi: 10.1016/S0140-6736(14)61409-4. Epub 2014 Sep 11.

Authors

Laura A Young¹, John B Buse²

Affiliations

¹ Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC 27599-7172, USA.
² Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC 27599-7172, USA. Electronic address: jbuse@med.unc.edu.

PMID: 25220193
DOI: 10.1016/S0140-6736(14)61409-4

No abstract available

Publication types

Comment

MeSH terms

Diabetes Mellitus, Type 2 / drug therapy*
Humans
Hypoglycemic Agents / therapeutic use*
Insulin, Long-Acting / therapeutic use*
Receptors, Glucagon / agonists*

Substances

Hypoglycemic Agents
Insulin, Long-Acting
Receptors, Glucagon